Boston Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Boston Partners's OGN Position: Q4 2024 in Review
Boston Partners sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 860,699 shares — an estimated $16.3M sold.
Boston Partners first reported a position in OGN in Q1 2024 and held it in 3 quarters. The position peaked at $20.5M in Q2 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.
- Boston Partners reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
- Boston Partners sold 860,699 Organon & Co shares in Q4 2024, an estimated $16.3M.
- Boston Partners first reported a position in Organon & Co in Q1 2024 and held it in 3 quarters.
- Boston Partners's Organon & Co position peaked at $20.5M in Q2 2024.
- 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.
Based on Boston Partners's 13F filing for Q4 2024, filed 11 Feb 2025.